On July 17, 2024, Richard A. Gonzalez, the Executive Chairman of the Board at AbbVie Inc., completed a significant transaction involving the sale of company stock. Gonzalez sold a total of 282,845 shares of AbbVie's common stock at a price of $175.00 per share, resulting in a total market value of $49,497,875. This transaction followed a series of derivative security exercises on the same day, where Gonzalez acquired shares at prices ranging from $61.36 to $93.50. After these transactions, Gonzalez's direct holdings in AbbVie common stock amounted to 513,099 shares. The sale represents a notable change in Gonzalez's investment in the company and is a key event for investors monitoring insider activity.

On July 17, 2024, Richard A. Gonzalez, the Executive Chairman of the Board at AbbVie Inc., completed a significant transaction involving the sale of company stock. Gonzalez sold a total of 282,845 shares of AbbVie's common stock at a price of $175.00 per share, resulting in a total market value of $49,497,875. This transaction followed a series of derivative security exercises on the same day, where Gonzalez acquired shares at prices ranging from $61.36 to $93.50. After these transactions, Gonzalez's direct holdings in AbbVie common stock amounted to 513,099 shares. The sale represents a notable change in Gonzalez's investment in the company and is a key event for investors monitoring insider activity.